Verrica Pharmaceuticals Inc (VRCA)
1.44
-0.09
(-5.88%)
USD |
NASDAQ |
Nov 04, 16:00
1.05
-0.39
(-27.08%)
After-Hours: 20:00
Verrica Pharmaceuticals Market Cap: 61.44M for Nov. 4, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 04, 2024 | 61.44M |
| November 01, 2024 | 65.28M |
| October 31, 2024 | 59.74M |
| October 30, 2024 | 68.27M |
| October 29, 2024 | 71.68M |
| October 28, 2024 | 66.56M |
| October 25, 2024 | 64.43M |
| October 24, 2024 | 64.00M |
| October 23, 2024 | 64.43M |
| October 22, 2024 | 67.84M |
| October 21, 2024 | 66.99M |
| October 18, 2024 | 68.27M |
| October 17, 2024 | 62.30M |
| October 16, 2024 | 64.43M |
| October 15, 2024 | 59.31M |
| October 14, 2024 | 60.59M |
| October 11, 2024 | 57.18M |
| October 10, 2024 | 55.04M |
| October 09, 2024 | 54.62M |
| October 08, 2024 | 54.62M |
| October 07, 2024 | 57.18M |
| October 04, 2024 | 55.90M |
| October 03, 2024 | 61.87M |
| October 02, 2024 | 47.36M |
| October 01, 2024 | 58.46M |
| Date | Value |
|---|---|
| September 30, 2024 | 61.87M |
| September 27, 2024 | 72.11M |
| September 26, 2024 | 71.68M |
| September 25, 2024 | 70.83M |
| September 24, 2024 | 75.10M |
| September 23, 2024 | 74.67M |
| September 20, 2024 | 77.23M |
| September 19, 2024 | 82.78M |
| September 18, 2024 | 78.94M |
| September 17, 2024 | 75.52M |
| September 16, 2024 | 80.64M |
| September 13, 2024 | 84.06M |
| September 12, 2024 | 82.78M |
| September 11, 2024 | 82.35M |
| September 10, 2024 | 83.20M |
| September 09, 2024 | 81.50M |
| September 06, 2024 | 81.50M |
| September 05, 2024 | 88.75M |
| September 04, 2024 | 98.14M |
| September 03, 2024 | 93.02M |
| August 30, 2024 | 100.27M |
| August 29, 2024 | 104.11M |
| August 28, 2024 | 99.42M |
| August 27, 2024 | 104.96M |
| August 26, 2024 | 109.66M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
47.36M
Minimum
Oct 02 2024
449.26M
Maximum
Nov 26 2019
245.32M
Average
249.23M
Median
Market Cap Benchmarks
| Biomarin Pharmaceutical Inc | 12.58B |
| Elite Pharmaceuticals Inc | 544.93M |
| Eagle Pharmaceuticals Inc | 6.494M |
| TELA Bio Inc | 70.43M |
| Terns Pharmaceuticals Inc | 499.57M |
Market Cap Related Metrics
| PS Ratio | 4.765 |
| PEG Ratio | -0.0029 |
| Price | 1.44 |
| Earnings Yield | -132.2% |
| PEGY Ratio | -0.0029 |